Anakinra + Adalimumab Atto Interaction
Majorinteraction on record
Description
Increased risk of serious infection when combined with AMJEVITA. Concomitant use not recommended in RA patients.
Mechanism
TNF blocker combined with other biologic DMARD
Source: NLP:adalimumab-atto